Anthera Pharmaceuticals
Anthera Pharmaceuticals is focused on developing products to treat diseases associated with inflammation and autoimmune diseases.
Launch date
Employees
Market cap
€562k
Enterprise valuation
(€7m) (Public information from Sep 2024)
Share price
$0.0001 ANTH
Hayward California (HQ)
Authorizing premium user...